| Reference | Experiment Type | Cell/Tissue/Microbe/Strain | Test Organism | Lifestage | Administration Method | Target Organism | Administered Dose Range | Significant Dose Range | Time to Death of Pathogen (min) | Anthelminthic Efficacy (%) | Therapeutic Action |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PMID:23825733 | In vitro | - | Clarias gariepinus | - | - | Edwardsiella tarda | 62500.0-125000.0 μg/mL |
62500.0-125000.0 μg/mL |
- | - | Antibacterial |
| In vitro | - | Lates calcarifer | - | - | Edwardsiella spp. | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Escherichia coli | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Pseudomonas spp. | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Salmonella spp. | 15625.0 μg/mL |
15625.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Streptococcus spp. | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Lates calcarifer | - | - | Vibrio damsela | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Aeromonas spp. | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Edwardsiella spp. | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Escherichia coli | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Salmonella spp. | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 8090 | - | - | - | Citrobacter freundii | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Macrobrachium rosenbergii | - | - | Vibrio spp. | 31250.0 μg/mL |
31250.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Monopterus albus | - | - | Edwardsiella tarda | 15625.0-62500.0 μg/mL |
15625.0-62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Penaeus monodon | - | - | Vibrio spp. | 15625.0 μg/mL |
15625.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Penaeus vannamei | - | - | Vibrio spp. | 15625.0 μg/mL |
15625.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Aeromonas spp. | 125000.0 μg/mL |
125000.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Edwardsiella spp. | 250000.0 μg/mL |
250000.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Flavobacterium spp. | 125000.0 μg/mL |
125000.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC13813 | - | - | - | Streptococcus agalactiae | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Rana catesbeiana | - | - | Vibrio spp. | 31250.0 μg/mL |
31250.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Tilapia sp. | - | - | Edwardsiella tarda | 15625.0-32500.0 μg/mL |
15625.0-32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Trichogaster pectoralis | - | - | Edwardsiella tarda | 15625.0-62500.0 μg/mL |
15625.0-62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 15947 | - | - | - | Edwardsiella tarda | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 23715 | - | - | - | Yersinia enterocolitica | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 25922 | - | - | - | Escherichia coli | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 35032 | - | - | - | Pseudomonas aeruginosa | 32500.0 μg/mL |
32500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC 49140 | - | - | - | Aeromonas hydrophila | 62500.0 μg/mL |
62500.0 μg/mL |
- | - | Antibacterial | |
| In vitro | - | Scylla sp. | - | - | Vibrio spp. | 15625.0 μg/mL |
15625.0 μg/mL |
- | - | Antibacterial | |
| PMID:29741243 | In vitro | MF372511 | - | - | - | Raoultella ornithinolytica | 400.0-800.0 μg/mL |
400.0-800.0 μg/mL |
- | - | Antibacterial |
| In vitro | MF565839 | - | - | - | Citrobacter freundii | 400.0-800.0 μg/mL |
400.0-800.0 μg/mL |
- | - | Antibacterial | |
| In vitro | MF 372510 | - | - | - | Aeromonas hydrophila | 2.5-50.0 μg/mL |
2.5-50.0 μg/mL |
- | - | Antibacterial | |
| In vitro | ATCC7966 | - | - | - | Aeromonas hydrophila | 200.0 μg/mL |
200.0 μg/mL |
- | - | Antibacterial | |
| PMID:32119179 | In vitro | ATCC14174 | - | - | - | Aeromonas salmonicida | 250.0 μg/mL |
250.0 μg/mL |
- | - | Antibacterial |
| In vitro | CAE235 | - | - | - | Aeromonas salmonicida | 250.0 μg/mL |
250.0 μg/mL |
- | - | Antibacterial | |
| In vitro | CAE258 | - | - | - | Aeromonas salmonicida | 250.0 μg/mL |
250.0 μg/mL |
- | - | Antibacterial | |
| In vitro | CAE452 | - | - | - | Aeromonas salmonicida | 125.0 μg/mL |
125.0 μg/mL |
- | - | Antibacterial | |
| PMID:38964434 | In vitro | Grouper spleen (GS) cell line | Epinephelus coioides | - | - | Singapore grouper iridovirus (SGIV) | 50.0-150.0 μM |
100.0 μM |
- | - | Anti-inflammatory |
| In vitro | Grouper spleen (GS) cell line | Epinephelus coioides | - | - | Singapore grouper iridovirus (SGIV) | 100.0 μM |
100.0 μM |
- | - | Antioxidant | |
| In vitro | Grouper spleen (GS) cell line | Epinephelus coioides | - | - | Singapore grouper iridovirus (SGIV) | 100.0 μM |
100.0 μM |
- | - | Biochemistry modulator | |
| In vitro | Grouper spleen (GS) cell line | Epinephelus coioides | - | - | Singapore grouper iridovirus (SGIV) | 100.0 μM |
100.0 μM |
- | - | Immunostimulant | |
| In vitro | Grouper spleen (GS) cell line | Epinephelus coioides | - | - | Singapore grouper iridovirus (SGIV) | 50.0-150.0 μM |
50.0-150.0 μM |
- | - | Antiviral |
ReCAnt is a database of chemicals used in aquaculture and their ecotoxic effects, compiled from published literature. The authors are not liable for any inaccuracies or omissions of any chemicals in this resource. Importantly, our sole goal to build this resource on chemicals used in aquaculture is to enable future basic research on this topic, and it does not necessarily reflect the views or objectives of our employers or funders.